SOFIE and Mayo Clinic collaborate to secure $3M NIH grant for FAPI clinical trial
The National Cancer Institute (NCI) has awarded Mayo Clinic (Rochester), in partnership with SOFIE, a […]
The National Cancer Institute (NCI) has awarded Mayo Clinic (Rochester), in partnership with SOFIE, a […]
Dulles, VA – January 17, 2023 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]
Dulles, VA – November 29, 2022 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]
Dulles, VA – October 31, 2022 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]
SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, has dosed and imaged […]
Congratulations to investigators at Hannover School of Medicine and Heidelberg University Hospital for receiving the […]
SOFIE hosted a FAP session, together with Clovis […]
Dulles, VA, April 27, 2022– SOFIE Co. (SOFIE), a Theranostics company, commissions its new […]
Dulles, VA – November 10, 2021 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]
Dulles, VA – October 12, 2021 – SOFIE Biosciences (SOFIE), an established US manufacturer and […]